NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2024
Back to search
Official data from USPTO
LBIOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
01/10/2025
Trademark type
Combined
Nice classes
5, 40, 42
Filing date
05/20/2021
Registration date
04/25/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/25/2023
Last transaction
01/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
FR
Examiner
AYALA, LOURDES
Law office
L60
Current location
PETITIONS OFFICE
Mark description
The mark consists of the stylized wording "LBIOME" and design featuring the letters LB semi-connected and the letter O featured as a circle with ten small ovals, on a tilt, inside the circle.
Holders and representatives
Holders
DSM - Firmenich Houdan SAS
Adare Pharmaceuticals SAS
Representatives
Duane M. Byers Nixon & Vanderhye P.C.
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparationspharmaceutical preparations for the treatment and prevention of gastrointestinal infectionsdysbiosisdiarrheairritable bowel syndromeinflammatory bowel diseaseabdominal paincolitisvaginal infectionsobesityallergystressanxietyautismsdepressionmood disturbancesociability disturbancesleep disturbancepsychological disturbanceobsessive-compulsive disordersaddictionfibromyalgiacancerpost-traumatic stressmucosal and systemic inflammationnecrotizing enterocolitisenteritisskin inflammationskin infectionsveterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal infectionsdysbiosisdiarrheairritable bowel syndromeinflammatory bowel diseaseabdominal paincolitisvaginal infectionsobesityallergystressanxietydepressionmood disturbancesociability disturbancesleep disturbancefibromyalgiacancerpost-traumatic stressmucosal and systemic inflammationenteritisskin inflammationskin infections; dietetic foods adapted for medical and veterinary use; bacterial preparations for medical and veterinary use; probiotic bacteria preparations for medical use; foodstuffs and nutritional and food supplements featuring live or inactivated microorganismsnutritional supplementsenzyme food supplementsdietary food supplementsfood supplements for humans and animals; ingredients based on inactive bacteria preparations and heattreated and heat-stabilized bacteria preparationsLactobacillus strains in combination with fermentation medium featured as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; ingredients based on combinations of inactivated and heat-treated Lactobacillus delbrueckii and Lactobacillus fermentum and fermentation medium sold as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; additives in the nature of dietary supplements for humans or for animals; ferments for medical or veterinary use with postbiotic or probiotic effects
Class 40
Customized manufacturefor third partiesof pharmaceuticalsnutritional and food supplements featuring live or inactivated microorganisms; manufacture of ingredients comprising inactivatedheat-treated Lactobacillus strains and their fermentation mediumLactobacillus LBconsisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; custom manufacturefor third partiesof pharmaceutical and nutritional supplemental ingredientsenriched culture medium and heat-treated microorganisms; manufacture of pharmaceutical ingredientsheat-treated micro-organismsfor preparation of tabletscapsulespowdersinjectable productssuspensionsliquidsfor medical and veterinary use
Class 42
Medical and pharmaceutical research and development in the field of microbiologyimmunologymucosal immunologygastroenterologyinternal medicinepsychologypsychiatryneurologybehavioral scienceinflammatory disorderssarcopeniahealth by nutritiondermatitisallergiesinfectiologyendocrinologypostbiotics; scientific research and development; bacteriological scientific research and consultation; provision of information and data relating to medical and veterinary research and development; provision of scientific and technological information in the field of microbiologyimmunologymucosal immunologygastroenterologyinternal medicinepsychologypsychiatryneurologybehavioral scienceinflammatory disorderssarcopeniahealth by nutritiondermatitisallergiesinfectiologyendocrinologypostbiotics; design and development of pharmaceuticalsnutritional supplements and dietetic supplements comprising living and inactivated microorganisms; research and development of formulationspharmaceuticalsnutritional supplementsdietary supplements for the administration of heat-treated Lactobacillus strains combined with their fermentation mediumLactobacillus LBconsisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; research and development of pharmaceutical ingredients based on enriched culture medium and heat-treated bacteriaLactobacillus strains; research and development of formulationspharmaceutialsnutritional supplementsdietetic supplementsbased on enriched culture medium and heat-treated micro-organisms; technological consultation in the field of bacteria-based ingredients and in the field of postbiotics
Publications
History of USPTO decisions and trademark events.
50 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/19/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/20/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/02/2023
FIMP
FINAL DISPOSITION PROCESSED
08/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/25/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/25/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/25/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/14/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/22/2023
CHPB
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
02/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2023
PUBO
PUBLISHED FOR OPPOSITION
02/07/2023
APET
ASSIGNED TO PETITION STAFF
02/01/2023
PPAR
POST PUBLICATION AMENDMENT RECEIVED
02/01/2023
APET
ASSIGNED TO PETITION STAFF
01/30/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/18/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/31/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/30/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/30/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/03/2022
GNFR
FINAL REFUSAL E-MAILED
09/03/2022
CNFR
FINAL REFUSAL WRITTEN
09/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/26/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/26/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/26/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/26/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/26/2022
RFNT
REFUSAL PROCESSED BY IB
03/27/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/09/2022
RFRR
REFUSAL PROCESSED BY MPU
03/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2022
CNRT
NON-FINAL ACTION WRITTEN
02/10/2022
DOCK
ASSIGNED TO EXAMINER
02/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/28/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/16/2021
Continuous trademark protection
Get notified about every new filing that threatens LBIOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.